Respiratory Depression Associated with Opioids: A Narrative Review

Curr Treat Options Oncol. 2024 Nov;25(11):1438-1450. doi: 10.1007/s11864-024-01274-5. Epub 2024 Oct 21.

Abstract

All opioids have a risk of causing respiratory depression and reduced cerebral circulation. Fentanyl has the greatest risk of causing both. This is particularly a concern when combined with illicit opioids such as diamorphine (also known as heroin). Fentanyl should not be used as a frontline potent opioid due its significant risks. Buprenorphine, a schedule III opioid, morphine, or hydromorphone is preferred, followed by oxycodone, which has a significant risk of abuse relative to buprenorphine and morphine. Although all opioids were equally effective in producing analgesia, the relative safety of each opioid is no longer a secondary concern when prescribing. In the face of an international opioid epidemic, clinicians need to choose opioid analgesics safely, wisely, and carefully.

Keywords: Depression; Fentanyl; Nalmefene; Naloxone; Opioid; Respiratory.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid* / adverse effects
  • Analgesics, Opioid* / therapeutic use
  • Humans
  • Respiratory Insufficiency* / etiology

Substances

  • Analgesics, Opioid